These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 16531819

  • 1. Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells.
    Bontkes HJ, Ruizendaal JJ, Kramer D, Santegoets SJ, Scheper RJ, de Gruijl TD, Meijer CJ, Hooijberg E.
    J Immunother; 2006; 29(2):188-200. PubMed ID: 16531819
    [Abstract] [Full Text] [Related]

  • 2. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
    Harada S, Kimura T, Fujiki H, Nakagawa H, Ueda Y, Itoh T, Yamagishi H, Sonoda Y.
    Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
    [Abstract] [Full Text] [Related]

  • 3. New cytokine-dependent acute myeloid leukemia cell line MUTZ-11 with disomic chromosome rearrangement t(16;17).
    Hu ZB, Quentmeier H, Meyer C, Kaufmann M, MacLeod RA, Drexler HG.
    Leuk Res; 2004 May; 28(5):509-15. PubMed ID: 15068904
    [Abstract] [Full Text] [Related]

  • 4. Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model.
    St Louis DC, Woodcock JB, Franzoso G, Blair PJ, Carlson LM, Murillo M, Wells MR, Williams AJ, Smoot DS, Kaushal S, Grimes JL, Harlan DM, Chute JP, June CH, Siebenlist U, Lee KP.
    J Immunol; 1999 Mar 15; 162(6):3237-48. PubMed ID: 10092775
    [Abstract] [Full Text] [Related]

  • 5. MUTZ-3-derived dendritic cells as an in vitro alternative model to CD34+ progenitor-derived dendritic cells for testing of chemical sensitizers.
    Nelissen I, Selderslaghs I, Heuvel RV, Witters H, Verheyen GR, Schoeters G.
    Toxicol In Vitro; 2009 Dec 15; 23(8):1477-81. PubMed ID: 19732821
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
    Kremser A, Dressig J, Grabrucker C, Liepert A, Kroell T, Scholl N, Schmid C, Tischer J, Kufner S, Salih H, Kolb HJ, Schmetzer H.
    J Immunother; 2010 Dec 15; 33(2):185-99. PubMed ID: 20139775
    [Abstract] [Full Text] [Related]

  • 7. Ovarian carcinoma cells influence differentiation of Lin-CD45RA- dendritic cell precursors into two mature subtypes in vitro.
    Chen LL, Ye F, Yu Y, Chen HZ, Zhang WW, Lü WG, Xie X.
    Gynecol Oncol; 2009 Jan 15; 112(1):199-204. PubMed ID: 19022493
    [Abstract] [Full Text] [Related]

  • 8. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.
    Tan YF, Sim GC, Habsah A, Leong CF, Cheong SK.
    Malays J Pathol; 2008 Dec 15; 30(2):73-9. PubMed ID: 19291915
    [Abstract] [Full Text] [Related]

  • 9. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C, Liepert A, Dreyig J, Kremser A, Kroell T, Freudenreich M, Schmid C, Schweiger C, Tischer J, Kolb HJ, Schmetzer H.
    J Immunother; 2010 Jun 15; 33(5):523-37. PubMed ID: 20463595
    [Abstract] [Full Text] [Related]

  • 10. Generation of mature dendritic cells with unique phenotype and function by in vitro short-term culture of human monocytes in the presence of interleukin-4 and interferon-beta.
    Zhang LF, Okuma K, Tanaka R, Kodama A, Kondo K, Ansari AA, Tanaka Y.
    Exp Biol Med (Maywood); 2008 Jun 15; 233(6):721-31. PubMed ID: 18408138
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor alpha-stimulated endothelium: an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells.
    Moldenhauer A, Nociari M, Lam G, Salama A, Rafii S, Moore MA.
    Stem Cells; 2004 Jun 15; 22(2):144-57. PubMed ID: 14990854
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells.
    Pietra G, Mortarini R, Parmiani G, Anichini A.
    Cancer Res; 2001 Nov 15; 61(22):8218-26. PubMed ID: 11719453
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
    Tanaka F, Yamaguchi H, Haraguchi N, Mashino K, Ohta M, Inoue H, Mori M.
    Int J Oncol; 2006 Nov 15; 29(5):1263-8. PubMed ID: 17016660
    [Abstract] [Full Text] [Related]

  • 19. A CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursor.
    Santegoets SJ, Masterson AJ, van der Sluis PC, Lougheed SM, Fluitsma DM, van den Eertwegh AJ, Pinedo HM, Scheper RJ, de Gruijl TD.
    J Leukoc Biol; 2006 Dec 15; 80(6):1337-44. PubMed ID: 16959899
    [Abstract] [Full Text] [Related]

  • 20. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
    Naito K, Ueda Y, Itoh T, Fuji N, Shimizu K, Yano Y, Yamamoto Y, Imura K, Kohara J, Iwamoto A, Shiozaki A, Tamai H, Shimizu T, Mazda O, Yamagishi H.
    Int J Oncol; 2006 Jun 15; 28(6):1481-9. PubMed ID: 16685449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.